Target intelligence / Profile preview

NALF1 intronic transcript 1 (NALF1-IT1)

Target
NALF1-IT1
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

NALF1 intronic transcript 1 (NALF1-IT1) is a human long non-coding RNA (lncRNA) transcribed from an intronic region of the NALF1 gene. It is officially recognized in gene databases (HGNC:41503, NCBI Gene:100874375, Ensembl:ENSG00000227248) and is also known as FAM155A-IT1. NALF1-IT1 is classified as an lncRNA, meaning it does not code for protein but may have regulatory roles in gene expression, chromatin state, or RNA metabolism, although specific biological functions are not well-characterized in the current literature[3][5][7]. Disease association has been reported with myoclonic juvenile epilepsy, but causal or mechanistic details are lacking[3]. NALF1-IT1 is not considered a therapeutic target such as a receptor or enzyme and does not have known drug interactions, mechanisms of action, biomarker applications, or safety issues. Note: If your focus is on a molecule relevant for therapeutic targeting (such as for drug discovery), NALF1-IT1 is not appropriate, as it is a non-coding RNA transcript rather than a functional protein target. Confusion could arise between NALF1-IT1 and the protein-coding NALF1 (NALCN channel auxiliary factor 1), which *is* implicated in neuronal excitability and pain pathways[1][2]. If you need details about the protein-coding gene, please clarify; otherwise, the above information most accurately reflects the NALF1-IT1 lncRNA.

Other names
FAM155A-IT1
02

Biological functions

Other (non-coding RNA, possible regulation of host gene expression or chromatin, but no clear function available in the search results)
03

Disease associations

Epilepsy, Myoclonic Juvenile (association; no clear mechanistic disease role defined)

Beyond the preview

Go deeper on NALF1 intronic transcript 1 (NALF1-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NALF1 intronic transcript 1 (NALF1-IT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call